Technetium-99m sestamibi imaging to predict left ventricular ejection fraction outcome after revascularisation in patients with chronic coronary artery disease and left ventricular dysfunction: Comparison between baseline and nitrate-enhanced imaging

European Journal of Nuclear Medicine

Volumn 28, Issue 6, 2001, Pages 680-687

  Sciagrà, Roberto ^a   Leoncini, Mario ^b   Marcucci, Gabriella ^b   Dabizzi, Roberto P ^b   Pupi, Alberto ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b MISERICORDIA E DOLCE HOSPITAL   (Italy)

Author keywords

Ejection fraction; Nitrates; Revascularisation; Technetium 99m sestamibi; Viability

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; NITRATE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIAGNOSTIC ACCURACY; FEMALE; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE REVASCULARIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MYOCARDIAL HIBERNATION; RECEIVER OPERATING CHARACTERISTIC; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TREATMENT OUTCOME; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

ADULT; AGED; CHRONIC DISEASE; CORONARY ARTERIOSCLEROSIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; MIDDLE AGED; MYOCARDIAL REVASCULARIZATION; NITRATES; RADIOPHARMACEUTICALS; STROKE VOLUME; TECHNETIUM TC 99M SESTAMIBI; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT;

EID: 0034998030     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002590100543     Document Type: Article

References (31)

1. Beanlands RSB, Dawood F, Wen W-H, McLaughlin PR, Butany J, D'Amati G, Liu PP. Are the kinetics of technetium-99m methoxyisobutyl isonitrile affected by cell metabolism and viability? Circulation 1990; 82:1802-1814.
2. 201T1 to myocardial blood flow in a canine model of myocardial ischemic insult. Circulation 1990; 81:289-296.
3. Sinusas AJ, Trautman KA, Bergin JD, Watson DD, Ruiz M, Smith WH, Beller GA. Quantification of area at risk during coronary occlusion and degree of myocardial salvage after reperfusion with technetium-99m methoxyisobutyl isonitrile. Circulation 1990; 82:1424-1437.
4. Cuocolo A, Pace L, Ricciardelli B, Chiariello M, Trimarco B, Salvatore M. Identification of viable myocardium in patients with chronic coronary artery disease: comparison of thallium-201 scintigraphy with reinjection and technetium-99m-methoxyisobutyl isonitrile. J Nucl Med 1992; 33:505-511.
5. Sawada SG, Allman KC, Muzik O, Beanlands RSB, Wolfe ER Jr, Gross M, Lorraine F, Schwaiger M. Positron emission tomography detects evidence of viability in rest technetium-99m sestamibi defects. J Am Coll Cardiol 1994; 23:92-98.
6. Altehoefer C, von Dahl J, Biedermann M, Uebis R, Beilin I, Sheehan F, Hanrath P, Buell U. Significance of defect severity in technetium-99m-MIBI SPECT at rest to assess myocardial viability: comparison with fluorine-18-FDG PET. J Nucl Med 1994; 35:569-574.
7. Kauffman GJ, Boyne TS, Watson DD, Smith WH, Beller GA. Comparison of rest thallium-201 imaging and rest technetium-99m sestamibi imaging for assessment of myocardial viability in patients with coronary artery disease and severe left ventricular dysfunction. J Am Coll Cardiol 1996; 27:1592-1597.
8. 99mTc sestamibi in patients undergoing cardiac transplantation: a scintigraphic/pathological study. Circulation 1996; 94:1010-1017.
9. 99mTc-sestamibi. Circulation 1994; 89:2552-2561.
10. Maes AF, Borgers M, Flameng W, Nuyts JL, van de Werf F, Ausma JJ, Sergeant P, Mortelmans LA. Assessment of myocardial viability in chronic coronary artery disease using technetium-99m sestamibi SPECT: correlation with histologic and positron emission tomographic studies and functional follow up. J Am Coll Cardiol 1997; 29:62-68.
11. Bisi G, Sciagrà R, Santoro GM, Fazzini PF. Rest technetium-99m sestamibi tomography in combination with short-term administration of nitrates: feasibility and reliability for prediction of postrevascularization outcome of asynergic territories. J Am Coll Cardiol 1994; 24:1282-1289.
12. Maurea S, Cuocolo A, Soricelli A, Castelli L, Nappi A, Squame F, Imbriaco M, Trimarco B, Salvatore M. Enhanced detection of viable myocardium by technetium-99m-MIBI imaging after nitrate administration in chronic coronary artery disease. J Nucl Med 1995; 36:1945-1952.
13. Li ST, Liu XJ, Lu ZL, Shi RF, Zhu XD, Chen WQ, Wu QW, Liu YZ. Quantitative analysis of technetium 99m 2-methoxyisobutyl isonitrile single-photon emission computed tomography and isosorbide dinitrate infusion in assessment of myocardial viability before and after revascularization. J Nucl Cardiol 1996; 3:457-463.
14. Sciagrà R, Bisi G, Santoro GM, Agnolucci M, Zoccarato O, Fazzini PF. Influence of the assessment of defect severity and intravenous nitrate administration during tracer injection on the detection of viable hibernating myocardium with data-based quantitative technetium 99m-labeled sestamibi single photon emission computed tomography. J Nucl Cardiol 1996; 3:221-230.
15. Sciagrà R, Bisi G, Santoro GM, Zerauschek F, Sestini S, Pedenovi P, Pappagallo R, Fazzini PF. Comparison of baseline-nitrate technetium-99m-sestamibi with rest-redistribution thallium-201 tomography in detecting viable hibernating myocardium and predicting postrevascularization recovery. J Am Coll Cardiol 1997; 30:384-391.
16. Marwick TH. The viable myocardium: epidemiology, detection, and clinical implications. Lancet 1998; 351:815-819.
17. Tillisch JH, Brunken R, Marshall R, Schwaiger M, Mandelkern M, Phelps M, Schelbert H. Reversibility of cardiac wall motion abnormalities predicted by positron tomography. N Engl J Med 1986; 314:884-888.
18. Vom Dahl J, Eitzman DT, Al-Aouar ZR, Kanter HL, Hicks RJ, Deeb GM, Kirsh MM, Schwaiger M. Relation of regional function, perfusion, and metabolism in patients with advanced coronary disease undergoing surgical revascularization. Circulation 1994; 90:2356-2366.
19. Pasquet A, Lauer MS, Williams MJ, Secknus MA, Lytle B, Marwick TH. Prediction of global left ventricular function after bypass surgery in patients with severe left ventricular dysfunction. Impact of pre-operative myocardial function, perfusion, and metabolism. Eur Heart J 2000; 21:125-136.
20. Vanoverschelde J-LJ, D'Hondt A-M, Marwick T, Gerber BL, De Kock M, Dion R, Wijns W, Melin JA. Head-to-head comparison of exercise-redistribution-reinjection thallium single-photon emission computed tomography and low dose dobutamine echocardiography for prediction of reversibility of chronic left ventricular ischemic dysfunction. J Am Coll Cardiol 1996; 28:432-442.
21. 201T1 imaging in detection of myocardial viability and prediction of improvement in left ventricular function after coronary bypass surgery in patients with severely depressed left ventricular function. Circulation 1993; 87:1630-1641.
22. Meluzin J, Cerný J, Frélich M, Stetka F, Spinarova L, Popelova J, Stipal R. Dobutamine echocardiography in predicting improvement in global left ventricular systolic function after coronary bypass or angioplasty in patients with healed myocardial infarcts. Am J Cardiol 1995; 76:877-880.
23. Bax JJ, Poldermans D, Elhendy A, Cornel JH, Boersma E, Rambaldi R, Roelandt JR, Fioretti PM. Improvement of left ventricular ejection fraction, heart failure symptoms and prognosis after revascularization in patients with chronic coronary artery disease and viable myocardium detected by dobutamine stress echocardiography. J Am Coll Cardiol 1999; 34:163-169.
24. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, Gutgesell H, Reichek N, Sahn D, Schnittger I, for the American Society of Echocardiography Committee of Standards, Subcommittee on Quantification of Two-Dimensional Echocardiography. Recommendation for quantification of the left ventricle by two-dimensional echocardiography. J Am Soc Echocardiogr 1989; 5:358-367.
25. Sciagrà R, Pellegri M, Pupi A, Bolognese L, Bisi G, Carnovale V, Santoro GM. Prognostic implications of Tc-99m sestamibi viability imaging and subsequent therapeutic strategy in patients with chronic coronary artery disease and left ventricular dysfunction. J Am Coll Cardiol 2000; 36:739-745.
26. Hanley JA, McNeil BJ. A method of comparing the areas under receiving operating characteristic curves derived from the same cases. Radiology 1983; 148:839-843.
27. Greco C, Tanzilli G, Ciavolella M, Sinatra R, Banci M, Schillaci O, Macrina F, Scopinaro F, Marino B, Campa PP. Nitroglycerin-induced changes in myocardial sestamibi uptake to detect tissue viability: radionuclide comparison before and after revascularization. Coron Artery Dis 1996; 7:877-884.
28. Brown BG, Bolson E, Petersen RB, Pierce CD, Dodge HT. The mechanisms of nitroglycerin action: stenosis vasodilatation as a major component of the drug response. Circulation 1981; 64:1089-1097.
29. Fam WM, McGregor M. Effect of nitroglycerin and dipyridamole on regional coronary resistance. Circ Res 1968; 22:649-659.
30. Sias TM, Watson DD, Beller GA. Is nitroglycerin useful for the enhancement of viability detection with myocardial perfusion imaging? Am Heart J 1999; 138:206-209.
31. Samady H, Elefteriades JA, Abbott BG, Mattera JA, McPherson CA, Wackers FJT. Failure to improve left ventricular function after coronary revascularization for ischemic cardiomyopathy is not associated with worse outcome. Circulation 1999; 100:1298-1304.